Critical Survey: Astrana Health (NASDAQ:ASTH) vs. Daxor (NASDAQ:DXR)

Daxor (NASDAQ:DXR) and Astrana Health (NASDAQ:ASTH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Risk & Volatility

Daxor has a beta of -0.09, meaning that its stock price is 109% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

Institutional & Insider Ownership

1.3% of Daxor shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 59.5% of Daxor shares are held by company insiders. Comparatively, 20.0% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Daxor and Astrana Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	1	1	0	2.50
Astrana Health	2	2	6	0	2.40

Daxor currently has a consensus target price of $25.00, suggesting a potential upside of 86.29%. Astrana Health has a consensus target price of $45.29, suggesting a potential upside of 113.14%. Given Astrana Health’s higher possible upside, analysts plainly believe Astrana Health is more favorable than Daxor.

Earnings and Valuation

This table compares Daxor and Astrana Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	$3.31 million	19.61	N/A	N/A	N/A
Astrana Health	$2.90 billion	0.41	$43.15 million	$0.19	111.83

Astrana Health has higher revenue and earnings than Daxor.

Profitability

This table compares Daxor and Astrana Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Astrana Health	1.04%	3.43%	1.87%

Summary

Astrana Health beats Daxor on 8 of the 11 factors compared between the two stocks.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.